ATE324903T1 - Zusammensetzungen enthaltend fötales hämoglobin und bakterielles endotoxin und fakultativ zusätzliche fötale leberkomponenten - Google Patents
Zusammensetzungen enthaltend fötales hämoglobin und bakterielles endotoxin und fakultativ zusätzliche fötale leberkomponentenInfo
- Publication number
- ATE324903T1 ATE324903T1 AT03003687T AT03003687T ATE324903T1 AT E324903 T1 ATE324903 T1 AT E324903T1 AT 03003687 T AT03003687 T AT 03003687T AT 03003687 T AT03003687 T AT 03003687T AT E324903 T1 ATE324903 T1 AT E324903T1
- Authority
- AT
- Austria
- Prior art keywords
- bacterial endotoxin
- fetal
- compositions containing
- optional additional
- fetal hemoglobin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03003687A EP1449535B1 (de) | 2003-02-18 | 2003-02-18 | Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE324903T1 true ATE324903T1 (de) | 2006-06-15 |
Family
ID=32731533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03003687T ATE324903T1 (de) | 2003-02-18 | 2003-02-18 | Zusammensetzungen enthaltend fötales hämoglobin und bakterielles endotoxin und fakultativ zusätzliche fötale leberkomponenten |
Country Status (20)
Country | Link |
---|---|
US (1) | US7968103B2 (de) |
EP (2) | EP1449535B1 (de) |
JP (1) | JP4619352B2 (de) |
KR (1) | KR101102481B1 (de) |
CN (1) | CN1750840A (de) |
AT (1) | ATE324903T1 (de) |
AU (1) | AU2004212703C1 (de) |
BR (1) | BRPI0407311B8 (de) |
CA (1) | CA2514485C (de) |
DE (1) | DE60304989T2 (de) |
DK (1) | DK1449535T3 (de) |
ES (1) | ES2263859T3 (de) |
IL (1) | IL169760A (de) |
IS (1) | IS2294B (de) |
MX (1) | MXPA05008797A (de) |
NO (1) | NO334003B1 (de) |
NZ (1) | NZ541417A (de) |
PL (1) | PL211789B1 (de) |
RU (1) | RU2366449C2 (de) |
WO (1) | WO2004073728A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007103427A2 (en) * | 2006-03-06 | 2007-09-13 | Wang Xiang H | Medical use of bilirubin and its structural analogues |
US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
US20100010102A1 (en) * | 2008-07-09 | 2010-01-14 | Board Of Regents, The University Of Texas System | Triggered release of drugs from polymer particles |
KR101742332B1 (ko) * | 2009-04-20 | 2017-05-31 | 갈렌바이오 인코포레이티드 | 생체분자로 세포를 형질감염시키기 위한 조성물 |
EP2789343A1 (de) * | 2013-04-11 | 2014-10-15 | Clinique La Prairie | Neue hämoglobinabgeleitete peptidbasierte pharmazeutische Zusammensetzungen |
WO2015008166A2 (en) * | 2013-07-12 | 2015-01-22 | Casey Patrick J | Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4473647A (en) * | 1981-02-27 | 1984-09-25 | Amf Inc. | Tissue culture medium |
US4987237A (en) * | 1983-08-26 | 1991-01-22 | Ribi Immunochem Research, Inc. | Derivatives of monophosphoryl lipid A |
JPS63503308A (ja) * | 1986-05-09 | 1988-12-02 | スローン‐ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ | 抗腫瘍療法のためのリポ多糖体及び天然因子の組成物及び治療方法 |
DE69021791T2 (de) | 1989-06-30 | 1996-05-02 | American Cyanamid Co | Verwendung eines phagozytise-aktievierenden Stoffes : LPS oder IL-2 zur Herstellung eines Arzneimittels zur Behandlung von Staphylococcus-aureus-Infektionen bei Kühen. |
JPH0690745A (ja) * | 1990-08-20 | 1994-04-05 | Chiba Seifun Kk | Lps産生菌、lps、lpsを含む医薬及び動物薬 |
DE69126183D1 (de) | 1990-08-20 | 1997-06-26 | Den Ichi Mizuno | LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente |
JPH0499481A (ja) * | 1990-08-20 | 1992-03-31 | Chiba Seifun Kk | 新規細菌、新規lps、新規免疫機能活性化剤、新規動物用免疫機能活性化剤 |
JPH04187640A (ja) | 1990-11-22 | 1992-07-06 | Chiba Seifun Kk | 経口・経皮免疫機能促進剤、動物用経口・経皮免疫機能促進剤 |
DE539610T1 (de) * | 1991-10-26 | 1993-12-16 | Torf Ets | Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen. |
JP3199081B2 (ja) | 1992-11-13 | 2001-08-13 | 味の素株式会社 | 抗腫瘍剤 |
DE4338812A1 (de) * | 1993-11-15 | 1995-05-18 | Braun Melsungen Ag | Verwendung von Lösungen von vernetztem Hämoglobin zur Bekämpfung des septischen und hämorrhagischen Schocks bei Säugetieren |
US5648343A (en) * | 1994-02-28 | 1997-07-15 | The University Of Georgia Research Foundation | Method for treating LPS-mediated disorders |
US5580724A (en) * | 1994-03-25 | 1996-12-03 | Board Of Regents, The University Of Texas System | Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis |
US20020065211A1 (en) * | 1995-03-23 | 2002-05-30 | Biopure Corporation | Increasing function of organs having reduced red blood cell flow |
DE69612671T2 (de) * | 1995-10-06 | 2004-08-05 | Vertex Pharmaceuticals Inc., Cambridge | Butyrat-medikamentvorstufen der milchsäure |
WO1997025061A1 (en) * | 1996-01-09 | 1997-07-17 | Bristol-Myers Squibb Company | De-myristolated lipopolysaccharide of gram-negative bacteria |
ATE211510T1 (de) * | 1997-02-04 | 2002-01-15 | Bekaert Sa Nv | Beschichtung enthaltend filme aus diamantartigem kohlenstoff und diamantartigem nanokomposit |
EP0856592A1 (de) | 1997-02-04 | 1998-08-05 | N.V. Bekaert S.A. | Beschichtung enthaltende Filme aus diamantartigem Kohlenstoff und diamantartigem Nanokomposit |
US6670323B1 (en) * | 1999-11-12 | 2003-12-30 | Baxter International, Inc. | Reduced side-effect hemoglobin compositions |
EP2295968B1 (de) * | 1999-12-03 | 2012-09-19 | Baxter International Inc. | Test für Pyrogenizität zum Gebrauch in Verbindung mit automatisierten Immunoassay-Systemen |
JP2004504264A (ja) | 2000-01-07 | 2004-02-12 | ユニバーシティ オブ シンシナティ | Th1又はth2リンパ球に制御される免疫応答の選択的活性化 |
WO2002017965A1 (fr) * | 2000-08-28 | 2002-03-07 | Akira Awaya | Compositions medicinales |
DE10103211C1 (de) * | 2001-01-24 | 2002-07-18 | Ursula Kastner | Kulturmedium |
-
2003
- 2003-02-18 EP EP03003687A patent/EP1449535B1/de not_active Expired - Lifetime
- 2003-02-18 AT AT03003687T patent/ATE324903T1/de active
- 2003-02-18 ES ES03003687T patent/ES2263859T3/es not_active Expired - Lifetime
- 2003-02-18 DK DK03003687T patent/DK1449535T3/da active
- 2003-02-18 DE DE60304989T patent/DE60304989T2/de not_active Expired - Lifetime
-
2004
- 2004-02-18 BR BRPI0407311A patent/BRPI0407311B8/pt active IP Right Grant
- 2004-02-18 AU AU2004212703A patent/AU2004212703C1/en not_active Expired
- 2004-02-18 NZ NZ541417A patent/NZ541417A/en not_active IP Right Cessation
- 2004-02-18 CN CNA2004800044076A patent/CN1750840A/zh active Pending
- 2004-02-18 KR KR1020057015264A patent/KR101102481B1/ko active IP Right Grant
- 2004-02-18 CA CA2514485A patent/CA2514485C/en not_active Expired - Lifetime
- 2004-02-18 PL PL378573A patent/PL211789B1/pl unknown
- 2004-02-18 WO PCT/EP2004/001553 patent/WO2004073728A2/en active Application Filing
- 2004-02-18 JP JP2006501878A patent/JP4619352B2/ja not_active Expired - Lifetime
- 2004-02-18 US US10/545,500 patent/US7968103B2/en active Active
- 2004-02-18 MX MXPA05008797A patent/MXPA05008797A/es active IP Right Grant
- 2004-02-18 RU RU2005126141/15A patent/RU2366449C2/ru active
- 2004-02-18 EP EP04712020A patent/EP1601371A2/de not_active Withdrawn
-
2005
- 2005-07-18 IS IS7940A patent/IS2294B/is unknown
- 2005-07-19 IL IL169760A patent/IL169760A/en active IP Right Grant
- 2005-09-02 NO NO20054087A patent/NO334003B1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20110578A2 (en) | MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS | |
MY144318A (en) | Methods of treating hiv infection. | |
SG163517A1 (en) | Antiviral compounds and methods | |
NO941786D0 (no) | Uretaner og ureaer som induserer cytokinproduksjon | |
IL207468A (en) | HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections | |
EP1673078A4 (de) | Benzylether- und benzylamino-beta-sekretase-hemmer zur behandlung von alzheimer-krankheit | |
MX2010006046A (es) | Moduladores de gamma secretasa. | |
WO2006078424A3 (en) | Polyherbal compositions and methods for treating viral infections | |
IL176298A (en) | Imidazo [5,4 – c] pyridine compounds, preparations containing them and these compounds for use in the treatment and prevention of viral infection | |
EP2182006A3 (de) | Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen | |
WO2006066079A3 (en) | Pyridazinone compounds | |
EP1594444A4 (de) | Verfahren und zusammensetzungen zur behandlung und prävention von staphylokokkus- und anderen bakteriellen infektionen | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
NO20054087D0 (no) | Preparater omfattende fotalt hemoglobin og bakterielt endotoksin og eventuelt ytterligere fotale leverkomponenter | |
MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
TW200731975A (en) | Novel combinations of medicaments for the treatment of respiratory diseases | |
WO2006034001A3 (en) | Methods of treating hiv infection | |
AU2002303817A1 (en) | Compositions and methods for treating or preventing convulsions or seizures | |
DE60335647D1 (de) | Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden | |
WO2010052575A3 (en) | Ngna compositions and methods of use | |
AU4568400A (en) | Sphingomyelinase inhibitor | |
WO2004110373A3 (en) | Therapeutic vaccine compositions for the treatment of type 1 diabetes | |
WO2005080549A3 (de) | Trioxacarcine und deren verwendung gegen infektionskrankheiten | |
EP1682518A4 (de) | Dikationische triarylanaloga als mittel gegen protozoen | |
EA200501277A1 (ru) | Ацилированные аминопропандиолы и аналоги и их применения в терапии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1449535 Country of ref document: EP |